Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology
Public Domain
-
2013/03/01
-
Details
-
Personal Author:
-
Description:Relevant dosimetry for toxicology studies involving multi-walled carbon nanotubes (MWCNT) has not been well described due to a lack of detailed occupational exposure assessments. In response, exposure assessment findings from U.S.-based MWCNT manufacturers and users were extrapolated to results of an inhalation study in mice. Inhalable and respirable personal breathing zone (PBZ) samples from 9 facilities were collected for the mass concentration of elemental carbon. Upon analysis, 95% of the PBZ samples found exposure concentrations to be <10 microg/m3 with an average inhalable concentration of 8.5 ug/m3. At facilities where respirable and inhalable PBZ samples were collected, respirable samples were approximately 25% of the inhalable size fraction. Using 10 microg/m3, standard worker ventilatory parameters, and assuming 11% alveolar deposition, alveolar deposition was calculated to be 10.56 microg/d. Extrapolation to mouse equivalence by surface area equals 5.2 ng/d. In complement, a 19 d inhalation exposure to MWCNT with daily alveolar depositions of 1250 ng (=240 d of human exposure at 10 microg/m3), 125 ng (=24 d), and 12.5 ng (=2.4 d) was conducted. Mice were sacrificed at day 0, 3, 28, and 84 post-exposure. Pulmonary cytotoxicity (LDH activity) and polymorphonuclear cell (PMN) influx were evident at the high dose through day 84. For the middle dose, no PMN influx was evident and cytotoxicity was significant only at day 0. Lung inflammatory gene expression was increased at the high and middle dose. Alveolar macrophages harvested after exposure and stimulated with LPS showed enhanced cytokine release at the high dose and day 0 for the middle dose. No exposure effects were observed at the lowest dose. These results show a no effect dose lies somewhere in between the middle (=456 d at 10 microg/m3) and low dose (=45.6 d). The findings stress the importance of exposure assessment when extrapolating results of animal MWCNT exposures to potential human outcomes. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:99
-
Volume:132
-
Issue:1
-
NIOSHTIC Number:nn:20042816
-
Citation:Toxicologist 2013 Mar; 132(1):99
-
Federal Fiscal Year:2013
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:The Toxicologist. Society of Toxicology 52nd Annual Meeting and ToxExpo, March 10-14, 2013, San Antonio, Texas
-
Collection(s):
-
Main Document Checksum:urn:sha-512:989b57173a2284f5b91d164493ba6f1b7af172abdbdb7a522228ebad0b4c928695e14445f6320450b5512a0ed8d13b96ab59f20d3cea3b0b9acd24d6d20b67e9
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like